The global market for Equine Healthcare was estimated at US$7.1 Billion in 2024 and is projected to reach US$10.8 Billion by 2030, growing at a CAGR of 7.2% from 2024 to 2030. This comprehensive report provides an in-depth analysis of market trends, drivers, and forecasts, helping you make informed business decisions. The report includes the most recent global tariff developments and how they impact the Equine Healthcare market.
The use of telemedicine and AI-driven diagnostics is making veterinary care more accessible, allowing for remote monitoring and early disease detection. Genetic testing is also gaining traction in equine breeding programs, helping breeders identify hereditary diseases and optimize selective breeding strategies. As equestrian sports grow in popularity, the need for specialized healthcare solutions tailored to performance horses is driving innovation in the industry.
Additionally, regenerative medicine techniques such as stem cell therapy and platelet-rich plasma (PRP) therapy are being used to treat musculoskeletal injuries in performance horses. Advanced diagnostic tools, including MRI and CT scans, are improving the accuracy of lameness detection and internal health assessments. As research in equine medicine continues to progress, the market is expected to witness increased adoption of personalized and data-driven healthcare solutions.
The integration of AI, telemedicine, and wearable health monitoring solutions is expanding access to veterinary care and improving disease management. Additionally, regulatory efforts to enforce equine health standards and vaccination programs are boosting market demand. As the equestrian industry continues to evolve, the equine healthcare market is expected to grow significantly, with innovations in diagnostics, treatment, and disease prevention leading the way.
Global Equine Healthcare Market - Key Trends & Drivers Summarized
Why Is Equine Healthcare Gaining More Attention?
The equine healthcare market is expanding as horse owners and trainers place greater emphasis on preventive care, advanced diagnostics, and performance optimization. Advances in veterinary medicine, including regenerative therapies, equine vaccines, and diagnostic imaging, are improving horse health and extending their athletic careers. The increasing awareness of zoonotic diseases and equine epidemics is driving demand for vaccinations, deworming treatments, and biosecurity measures.The use of telemedicine and AI-driven diagnostics is making veterinary care more accessible, allowing for remote monitoring and early disease detection. Genetic testing is also gaining traction in equine breeding programs, helping breeders identify hereditary diseases and optimize selective breeding strategies. As equestrian sports grow in popularity, the need for specialized healthcare solutions tailored to performance horses is driving innovation in the industry.
How Are Technological Innovations Transforming Equine Healthcare?
The adoption of wearable health monitoring devices for horses is revolutionizing equine healthcare. Smart sensors integrated into halters, saddles, and leg wraps can track vital signs, detect signs of lameness, and monitor hydration levels in real-time. AI-powered analytics are helping veterinarians identify health trends, predict potential injuries, and customize treatment plans.Additionally, regenerative medicine techniques such as stem cell therapy and platelet-rich plasma (PRP) therapy are being used to treat musculoskeletal injuries in performance horses. Advanced diagnostic tools, including MRI and CT scans, are improving the accuracy of lameness detection and internal health assessments. As research in equine medicine continues to progress, the market is expected to witness increased adoption of personalized and data-driven healthcare solutions.
What Are the Key Factors Driving Growth in the Equine Healthcare Market?
The growth in the equine healthcare market is driven by rising equestrian participation, advancements in veterinary technology, and increasing awareness of preventive care. The demand for specialized supplements, performance-enhancing therapies, and diagnostic imaging solutions is growing, particularly among professional horse owners.The integration of AI, telemedicine, and wearable health monitoring solutions is expanding access to veterinary care and improving disease management. Additionally, regulatory efforts to enforce equine health standards and vaccination programs are boosting market demand. As the equestrian industry continues to evolve, the equine healthcare market is expected to grow significantly, with innovations in diagnostics, treatment, and disease prevention leading the way.
Scope of Study:
The report analyzes the Equine Healthcare market in terms of units by the following Segments, and Geographic Regions/Countries:- Segments: Product Type (Vaccines, Pharmaceuticals, Medicinal Feed Additives, Orthobiologics, Diagnostics, Software & Services, Others); Indication (Musculoskeletal Disorders, Parasitic Infections, Equine Herpes Virus, Equine Viral Arteritis, Equine Influenza, West Nile Virus, Tetanus, Other Indications); Activity (Sports / Racing, Recreation, Other Activities); Distribution Channel (Veterinary Hospitals & Clinics, E-commerce, Equestrian Facilities, Other Channels)
- Geographic Regions/Countries: World; United States; Canada; Japan; China; Europe (France; Germany; Italy; United Kingdom; Spain; Russia; and Rest of Europe); Asia-Pacific (Australia; India; South Korea; and Rest of Asia-Pacific); Latin America (Argentina; Brazil; Mexico; and Rest of Latin America); Middle East (Iran; Israel; Saudi Arabia; United Arab Emirates; and Rest of Middle East); and Africa.
Key Insights:
- Market Growth: Understand the significant growth trajectory of the Vaccines segment, which is expected to reach US$3.4 Billion by 2030 with a CAGR of a 8.9%. The Pharmaceuticals segment is also set to grow at 6.0% CAGR over the analysis period.
- Regional Analysis: Gain insights into the U.S. market, estimated at $1.9 Billion in 2024, and China, forecasted to grow at an impressive 11.6% CAGR to reach $2.3 Billion by 2030. Discover growth trends in other key regions, including Japan, Canada, Germany, and the Asia-Pacific.
Why You Should Buy This Report:
- Detailed Market Analysis: Access a thorough analysis of the Global Equine Healthcare Market, covering all major geographic regions and market segments.
- Competitive Insights: Get an overview of the competitive landscape, including the market presence of major players across different geographies.
- Future Trends and Drivers: Understand the key trends and drivers shaping the future of the Global Equine Healthcare Market.
- Actionable Insights: Benefit from actionable insights that can help you identify new revenue opportunities and make strategic business decisions.
Key Questions Answered:
- How is the Global Equine Healthcare Market expected to evolve by 2030?
- What are the main drivers and restraints affecting the market?
- Which market segments will grow the most over the forecast period?
- How will market shares for different regions and segments change by 2030?
- Who are the leading players in the market, and what are their prospects?
Report Features:
- Comprehensive Market Data: Independent analysis of annual sales and market forecasts in US$ Million from 2024 to 2030.
- In-Depth Regional Analysis: Detailed insights into key markets, including the U.S., China, Japan, Canada, Europe, Asia-Pacific, Latin America, Middle East, and Africa.
- Company Profiles: Coverage of players such as Arthrex, Inc., Boehringer Ingelheim International GmbH, Cargill, Incorporated, Ceva Santé Animale, Covetrus Inc. and more.
- Complimentary Updates: Receive free report updates for one year to keep you informed of the latest market developments.
Some of the 42 companies featured in this Equine Healthcare market report include:
- Arthrex, Inc.
- Boehringer Ingelheim International GmbH
- Cargill, Incorporated
- Ceva Santé Animale
- Covetrus Inc.
- Dechra Pharmaceuticals PLC
- Elanco Animal Health Incorporated
- Esaote S.p.A.
- Hallmarq Veterinary Imaging
- Heska Corporation
- IDEXX Laboratories, Inc.
- Kyoritsu Seiyaku Corporation
- Merck & Co., Inc. (Merck Animal Health)
- Neogen Corporation
- Norbrook Laboratories Ltd.
- Purina Animal Nutrition LLC
- Vetoquinol S.A.
- Virbac
- W.F. Young, Inc.
- Zoetis Inc.
This edition integrates the latest global trade and economic shifts as of June 2025 into comprehensive market analysis. Key updates include:
- Tariff and Trade Impact: Insights into global tariff negotiations across 180+ countries, with analysis of supply chain turbulence, sourcing disruptions, and geographic realignment. Special focus on 2025 as a pivotal year for trade tensions, including updated perspectives on the Trump-era tariffs.
- Adjusted Forecasts and Analytics: Revised global and regional market forecasts through 2030, incorporating tariff effects, economic uncertainty, and structural changes in globalization. Includes segmentation by product, technology, type, material, distribution channel, application, and end-use, with historical analysis since 2015.
- Strategic Market Dynamics: Evaluation of revised market prospects, regional outlooks, and key economic indicators such as population and urbanization trends.
- Innovation & Technology Trends: Latest developments in product and process innovation, emerging technologies, and key industry drivers shaping the competitive landscape.
- Competitive Intelligence: Updated global market share estimates for 2025, competitive positioning of major players (Strong/Active/Niche/Trivial), and refined focus on leading global brands and core players.
- Expert Insight & Commentary: Strategic analysis from economists, trade experts, and domain specialists to contextualize market shifts and identify emerging opportunities.
- Complimentary Update: Buyers receive a free July 2025 update with finalized tariff impacts, new trade agreement effects, revised projections, and expanded country-level coverage.
Table of Contents
I. METHODOLOGYII. EXECUTIVE SUMMARY2. FOCUS ON SELECT PLAYERSIV. COMPETITION
1. MARKET OVERVIEW
3. MARKET TRENDS & DRIVERS
4. GLOBAL MARKET PERSPECTIVE
III. MARKET ANALYSIS
Companies Mentioned (Partial List)
A selection of companies mentioned in this report includes, but is not limited to:
- Arthrex, Inc.
- Boehringer Ingelheim International GmbH
- Cargill, Incorporated
- Ceva Santé Animale
- Covetrus Inc.
- Dechra Pharmaceuticals PLC
- Elanco Animal Health Incorporated
- Esaote S.p.A.
- Hallmarq Veterinary Imaging
- Heska Corporation
- IDEXX Laboratories, Inc.
- Kyoritsu Seiyaku Corporation
- Merck & Co., Inc. (Merck Animal Health)
- Neogen Corporation
- Norbrook Laboratories Ltd.
- Purina Animal Nutrition LLC
- Vetoquinol S.A.
- Virbac
- W.F. Young, Inc.
- Zoetis Inc.
Table Information
| Report Attribute | Details |
|---|---|
| No. of Pages | 501 |
| Published | July 2025 |
| Forecast Period | 2024 - 2030 |
| Estimated Market Value ( USD | $ 7.1 Billion |
| Forecasted Market Value ( USD | $ 10.8 Billion |
| Compound Annual Growth Rate | 7.2% |
| Regions Covered | Global |
